Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia

American Journal of Hypertension

Volumn 21, Issue 12, 2008, Pages 1343-1346

  Tsukimori, Kiyomi ^a   Yoshitomi, Tomoyuki ^a   Morokuma, Seiichi ^a   Fukushima, Kotaro ^a   Wake, Norio ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; HYDROGEN PEROXIDE; PEROXIDASE; REACTIVE OXYGEN METABOLITE; URATE OXIDASE; URIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; COLORIMETRY; FEMALE; HUMANS; HYDROGEN PEROXIDE; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; PROTEIN CARBONYLATION; SEVERITY OF ILLNESS INDEX; SUPEROXIDES; URIC ACID;

EID: 56549127833     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.289     Document Type: Article

References (28)

1. Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005; 46:1263-1269.
2. Powers RW, Bodnar LM, Ness RB, Cooper KM, Gallaher MJ, Frank MP, Daftary AR, Roberts JM. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol 2006; 194:160.e1-160.e8.
3. Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 1996; 174:288-291.
4. Chesley LC, Williams LO. Renal glomerular and tubal function in relation to the hyperuricemia of pre-eclampsia and eclampsia. Am J Obstet Gynecol 1945; 50:367-375.
5. Handler JS. The role of lactic acid in the reduced excretion of uric acid in toxemia of pregnancy. J Clin Invest 1960; 39:1526-1532.
6. Gallery ED, Hunyor SN, Györy AZ. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Q J Med 1979; 48:593-602.
7. Kang DH, Finch J, Nakagawa T, Karumanchi SA, Kanellis J, Granger J, Johnson RJ. Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens 2004; 22:229-235.
8. Lam C, Lim KH, Kang DH, Karumanchi SA. Uric acid and preeclampsia. Semin Nephrol 2005; 25:56-60.
9. Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta 2008; 29:S67-S72.
10. Parks DA, Williams TK, Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol 1988; 254:G768-G774.
11. Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000; 156:321-331.
12. Stadtman ER, Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev 1998; 30:225-243.
13. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:IX-XIV.
14. 2+ in the presence of xylenol orange. Free Radic Res 1999; 31:237-244.
15. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005; 46:1243-1249.
16. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357:53-56.
17. Wang Y, Walsh SW, Kay HH. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol 1992; 167:946-949.
18. Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 1996; 28:488-493.
19. Zusterzeel PL, Rütten H, Roelofs HM, Peters WH, Steegers EA. Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta 2001; 22:213-219.
20. Suzuki S, Yoneyama Y, Sawa R, Otsubo Y, Takeuchi T, Araki T. Relation between serum uric acid and plasma adenosine levels in women with preeclampsia. Gynecol Obstet Invest 2001; 51:169-172.
21. Zusterzeel PL, Mulder TP, Peters WH, Wiseman SA, Steegers EA. Plasma protein carbonyls in nonpregnant, healthy pregnant and preeclamptic women. Free Radic Res 2000; 33:471-476.
22. Kharfi A, Giguère Y, De Grandpré P, Moutquin JM, Forest JC. Human chorionic gonadotropin (hCG) may be a marker of systemic oxidative stress in normotensive and preeclamptic term pregnancies. Clin Biochem 2005; 38:717-721.
23. Lieppman RE, Williams MA, Cheng EY, Resta R, Zingheim R, Hickok DE, Luthy DA. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol 1993; 168:1852-1856.
24. Hsu CD, Chan DW, Iriye B, Johnson TR, Hong SF, Repke JT. Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia. Am J Obstet Gynecol 1994; 170:1135-1138.
25. Tsukimori K, Fukushima K, Tsushima A, Nakano H. Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies. Hypertension 2005; 46:696-700.
26. Harrison R. Physiological roles of xanthine oxidoreductase. Drug Metab Rev 2004; 36:363-375.
27. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 2004; 555:589-606.
28. Gülmezoǧlu AM, Hofmeyr GJ, Oosthuisen MM. Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. Br J Obstet Gynaecol 1997; 104:689-696.